Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
| Product Code | Hek293T; HEK-293T; HEK 293T; HEK-293-T; HEK 293 T; 293-T; 293 T; 293T; Human Embryonic Kidney 293T; 293tsA1609neo |
| Species | Human |
| Cat.No | ABC-TC441S |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Kidney |
| Storage | Liquid Nitrogen |
| Product Type | Human Kidney Cell Lines |
293T is a derivative cell line of the human embryonic kidney cell line HEK293, originally obtained by transforming HEK293 cells with adenovirus 5 DNA, and can be generated by the SV40 T antigen transfection. The 293T cells exhibit epithelial-like morphology and adherent culture characteristics. The stemline karyotype of this cell line is hyperdiploid, with a modal chromosome number of 64. 293T is an aneuploid cell line, displaying chromosomal counts within the near-triploid range. This cell line is tumorigenic and has a high transfection efficiency and is commonly used for lentivirus packaging, gene expression, and signal transduction studies.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
293T cells serve as a versatile platform for viral vector production (including retroviruses, lentiviruses, and adenoviruses) by efficiently packaging SV40 origin-containing vectors. Their high transferability supports transient gene expression studies and transfection assay optimization while enabling large-scale recombinant protein production for research/therapeutics. These cells additionally facilitate pseudovirus generation for viral entry/replication studies and drug discovery research targeting ion channels, protein interactions, and post-translational modifications, along with applications in RNA interference, cell cycle progression, and cancer metastasis.
